1. Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P

Frequency of TERT promoter mutations in human cancers. Nature communications 4: 2185, 2013.  [Article] 

 doi: 10.1038/ncomms3185 PMID: 23887589.

 

2. Prazeres H, Torres J, Rodrigues F, Pinto M, Pastoriza MC, Gomes D, Cameselle-Teijeiro J, Vidal A, Martins TC, Sobrinho-Simões M, Soares P

Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene 30: 1302-17, 2011.  [Article] 

 doi: 10.1038/onc.2010.512 PMID: 21057533.

 

3. Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas. The Journal of clinical endocrinology and metabolism 99: E754-65, 2014.  [Article] 

 doi: 10.1210/jc.2013-3734 PMID: 24476079.

 

4. Santos LR, Durães C, Mendes A, Prazeres H, Alvelos MI, Moreira CS, Canedo P, Esteves C, Neves C, Carvalho D, Sobrinho-Simões M, Soares P

A Polymorphism in the Promoter Region of the Selenoprotein S Gene (SEPS1) Contributes to Hashimoto's Thyroiditis Susceptibility. The Journal of clinical endocrinology and metabolism 99: E719-23, 2014.  [Article] 

 doi: 10.1210/jc.2013-3539 PMID: 24471570.

 

5. Máximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simões M

The biology and the genetics of Hurthle cell tumors of the thyroid. Endocrine-related cancer 19: R131-47, 2012.  [Review] 

 doi: 10.1530/ERC-11-0354 PMID: 22514109.

 

6. Prazeres H, Couto JP, Rodrigues F, Vinagre J, Torres J, Trovisco V, Martins TC, Sobrinho-Simões M, Soares P

In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp. Endocrine-related cancer 18: 401-12, 2011.  [Article] 

 doi: 10.1530/ERC-10-0258 PMID: 21551259.

 

7. Ferreira LB, Eloy C, Pestana A, Lyra J, Moura M, Prazeres H, Tavares C, Sobrinho-Simões M, Gimba E, Soares P

Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma. European journal of endocrinology 174: 551-61, 2016.  [Article] 

 doi: 10.1530/EJE-15-0577 PMID: 26811408.

 

8. Lyra J, Vinagre J, Batista R, Pinto V, Prazeres H, Rodrigues F, Eloy C, Sobrinho-Simões M, Soares P

mTOR activation in medullary thyroid carcinoma with RAS mutation. European journal of endocrinology 171: 633-40, 2014.  [Article] 

 doi: 10.1530/EJE-14-0389 PMID: 25163725.

 

9. Batista R, Vinagre J, Prazeres H, Sampaio C, Peralta P, Conceição P, Sismeiro A, Leão R, Gomes A, Furriel F, Oliveira C, Torres JN, Eufrásio P, Azinhais P, Almeida F, Gonzalez ER, Bidovanets B, Ecke T, Stinjs P, Pascual ÁS, Abdelmalek R, Villafruela A, Beardo-Villar P, Fidalgo N, Öztürk H, Gonzalez-Enguita C, Monzo J, Lopes T, Álvarez-Maestro M, Servan PP, De La Cruz SMP, Perez MPS, Máximo V, Soares P

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study. Frontiers in genetics 10: 1237, 2019.  [Article] 

 doi: 10.3389/fgene.2019.01237 PMID: 31921291.

 

10. Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC

Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Clinical endocrinology 64: 659-66, 2006.  [Article] 

 doi: 10.1111/j.1365-2265.2006.02524.x PMID: 16712668.

 

11. Sousa I, Rodrigues F, Prazeres H, Lima RT, Soares P

Liposomal therapies in oncology: does one size fit all? Cancer chemotherapy and pharmacology 82: 741-755, 2018.  [Review] 

 doi: 10.1007/s00280-018-3668-7 PMID: 30116847.

 

12. Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M

Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Current genomics 12: 609-17, 2011.  [Article] 

 doi: 10.2174/138920211798120853 PMID: 22654560.

 

13. Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M

Alterations in Poorly Differentiated and Unddiferentiated Thyroid Carcinomas Current genomics  1, 2011.  [] 

.

 

14. Couto JP, Prazeres H, Castro P, Lima J, Máximo V, Soares P, Sobrinho-Simões M

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer. Journal of clinical pathology 62: 414-21, 2009.  [Review] 

 doi: 10.1136/jcp.2008.055343 PMID: 19147628.

 

15. Prazeres HJ, Rodrigues F, Soares P, Naidenov P, Figueiredo P, Campos B, Lacerda M, Martins TC

Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam Cancer 7: 141-9, 2008.  [Article] 

 doi: 10.1007/s10689-007-9160-x PMID: 17823852.

 

16. Prazeres H, Torres J, Soares P, Sobrinho-Simões M

The familial counterparts of follicular cell--derived thyroid tumors. International journal of surgical pathology 18: 233-42, 2010.  [Review] 

 doi: 10.1177/1066896910366442 PMID: 20444727.

 

17. Prazeres H, Salgado C, Duarte C, Soares P

LRP1B (low density lipoprotein receptor-related protein 1B) Atlas Genet Cytogenet Oncol Haematol  ., 2013.  [] 

.

 

18. Prazeres H, Torres J, Rodrigues F, Couto JP, Vinagre J, Sobrinho-Simões M, Soares P

How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer. Journal of thyroid research 2011: 678357, 2011.  [] 

 doi: 10.4061/2011/678357 PMID: 21765992.